Exsilio Therapeutics
Exsilio Therapeutics is a biotechnology company developing genomic medicines for various diseases. Their platform uses naturally occurring genetic elements delivered via mRNA and lipid nanoparticles to precisely insert genes into the human genome. This approach aims for durable and potentially curative effects for genetic diseases, cancer, and autoimmune conditions.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $82M
Date: 25-Jun-2024
Investors: Novartis Venture Fund, Delos Capital, OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures, Deep Insight
Markets: Biotechnology, Genomics, mRNA Therapeutics
HQ: Boston, Massachusetts, United States
Founded: 2022
Website: https://exsiliotx.com/
LinkedIn: https://www.linkedin.com/company/exsiliotx
Crunchbase: https://www.crunchbase.com/organization/exsilio-therapeutics
Leave a Comment
Comments
No comments yet.